Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients.
Margot A CousinEric T MateyPatrick R BlackburnNicole J BoczekTammy M McAllisterTeresa M KruisselbrinkDusica Babovic-VuksanovicKonstantinos N LazaridisEric W KleePublished in: Molecular genetics & genomic medicine (2017)
Due to the disease complexity and medication needs of diagnostic odyssey patients, there may be immediate benefit obtained from early life PGx testing for many and most will likely find benefit in the future. These results require conscientious interpretation and management to be actionable for all prescribing physicians throughout the lifetime of the patient.